Immunotherapy in HIV Infected Persons Using Vaccines after Multi-Drug Treatment Read more about Immunotherapy in HIV Infected Persons Using Vaccines after Multi-Drug Treatment US Application 60/146,240Filed on 1999-07-28
Antiviral Genetic Target Within HIV GAG-POL Transframe Region Read more about Antiviral Genetic Target Within HIV GAG-POL Transframe Region US Application 60/141,072Filed on 1999-06-25
Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector Read more about Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector US Application 60/137,126Filed on 1999-05-28
IDENTIFICATION OF INHIBITORS OF THE HGF-MET uPA-PLASMIN NETWORK USING A NOVEL CELLULAR ASSAY Read more about IDENTIFICATION OF INHIBITORS OF THE HGF-MET uPA-PLASMIN NETWORK USING A NOVEL CELLULAR ASSAY US Application 60/130,613Filed on 1999-04-22
Peptides and Their Utility in Modulation of Behavior of Cells Expressing Alpha 3 Beta 1 Integrins Read more about Peptides and Their Utility in Modulation of Behavior of Cells Expressing Alpha 3 Beta 1 Integrins US Application 60/144,549Filed on 1999-07-15
T20/DP178 And T21/DP107 Are Activators of Human Phagocyte Formyl Peptide Receptors Read more about T20/DP178 And T21/DP107 Are Activators of Human Phagocyte Formyl Peptide Receptors US Application 60/132,686Filed on 1999-05-05
Method of Reversing Chemotherapeutic Drug Resistance in tumor or Cancer Cells Utilizing an Acidically-Modified Dominant Negative Read more about Method of Reversing Chemotherapeutic Drug Resistance in tumor or Cancer Cells Utilizing an Acidically-Modified Dominant Negative US Application 60/138,864Filed on 1999-06-11
Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of the Fv to Lower the Isoelectic Point Read more about Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of the Fv to Lower the Isoelectic Point US Application 60/249,805Filed on 2000-11-17
IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY Affinity Improvement of scFVsr ab's w/higher affinity for Mesothelin Read more about IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY Affinity Improvement of scFVsr ab's w/higher affinity for Mesothelin US Application 60/160,071Filed on 1999-05-27
Leukocyte Derived Anti-Viral Factors Read more about Leukocyte Derived Anti-Viral Factors US Application 60/162,262Filed on 1999-10-29